BPA Found to Affect Critical Hormones in Pregnant Women and Boys

October 4, 2012

A new study raises concern about the effects of BPA on thyroid hormone levels in pregnant women and in young boys.  BPA is found in plastic bottles, the lining of food and beverage cans, dental sealants and even in sales receipts.  Originally BPA was found to cause harmful synthetic estrogen-like effects.  Now we are learning that it impacts one of the most critical hormone groupings in pregnant women and children.  I teach physicians about testing newly pregnant women at a very specific time, for thyroid hormone levels (including TSH, Free T3, Free T4 and TPO Antibodies) because if left untreated, an imbalance in these hormones will lead to recurrent miscarriage, difficulty producing breast milk, and serious developmental challenges in a newborn.

Dr. Gina


CME Presentation Delivered by Dr. Cushman

July 13, 2012

Dr. Gina Cushman, founder of HealthBridge Management and HealthBridge Medical Center, delivered her final lecture in a live pharmacy CME series on thyroid health yesterday July 12th, 2012 at 8 PM EST through PharmCon.  The attendee feedback was very positive, with an audience for the series in excess of 3,000 licensed healthcare professionals.

Below are  a few of the comments we received from physicians, nurses and pharmacists in attendance…

“Excellent program. I learned a lot.”

“I have thyroid disease and it’s going to help me personally as well as professionally.”

“Very informative, very thorough”

“Best CE from PharmCom to date”

“Great speaker. One of the best CE lessons.”

“Thorough, well organized, excellent thanks so much, learned  a lot which i will incorporate in my practice.”

“Very informative, great presentation!!!!”

“This presentation will be very helpful in my practice.”

“Excellent presentation. wonderful slides”

“Very informative”

“Super”

“Fantastic CE”

“Well-organized, knowledgeable speaker. Excellent review of thyroid disease basics, as well as an outstanding discussion of various treatment options.”

“Loved the presentation”

Check back here for news on upcoming live CME presentations offered by HealthBridge and Dr. Gina Cushman.


How to Optimize Thyroid Function

December 13, 2011

Dr. Gina Cushman is delivering a second live online Continuing Medical Education presentation this Thursday, December 15th from 9 PM to 10:15 PM ET.

The presentation topic is: “Innovative Strategies for Optimizing Thyroid Function.” Healthcare practitioners (including licensed physicians, pharmacists, nurses and naturopathic physicians) receive LIVE pharmacy credit hours by logging on at www.freece.com and registering for Dr. Cushman’s talk.

Just a few comments from physicians and pharmacists who have attended Dr. Cushman’s presentation:

“Excellent breakdown and explanation of the key differences between thyroid products.”

“Would love to see more programs with Dr. Gina – so interesting – she is GREAT!”

“Excellent speaker and welcomed content!”

The lecture is free to members and only $30 for non-members and you receive 1.25 hours of live continuing medical education credits!

Hope to see you there!


Thyroid Imbalance Epidemic

February 1, 2011

Sharing a post from Dr. Gary Gordon, emphasizing the importance of diagnosing and treating thyroid imbalances.  At our office, we have found  Thyroflex to be an excellent way to assess the functioning of the thyroid gland. We also test the blood for the active hormones and find that the results from our Thyroflex readings are more accurate and more valuable in terms of adequately treating thyroid imbalances.  The result is that our patients feel more energy, are able to maintain their desired weight, and experience a stronger immune system and a more positive attitude.

Here’s to supporting your body’s ability to heal itself, and regaining energy, vitality and a greater sense of well-being.

In health,

Dr. G

Thyroid Support Epidemic

February 1, 2011 by Dr. Garry Gordon

There is an epidemic of patients who need thyroid support! The attached Pubmed report shows how thyroid can protect pregnancies from untoward outcomes.

Nonetheless, the current January 2011 Townsend Newsletter reports that the Oregon Medical Board is attacking a licensed MD there for prescribing thyroid, because the indicated T4 and TSH target levels were not present. They are ignoring all of the overwhelming clinical evidence that the patient needed, and benefited by, the thyroid prescription. As one nutritional therapist and patient of this doctor declares, the Oregon Medical Board should emulate the doctor – not pursue internal complaints.

This is very sad since subclinical hypothyroidism is EPIDEMIC in our toxic world. Just consider the levels of Fluoride and Bromide present today that induce iodine deficiency in our population, as one cause of suboptimal thyroid function. For many other causes please consider owning the new text on Nutritional Medicine by Dr. Alan Gaby with nearly 30,000 references behind it.

View the report below on levothyroxine and infertile women with hypothyroidism. How many miscarriages or other pregnancy problems would be eliminated if doctors were not living in fear of their medical licenses? Read Dr. Broda Barnes’ book on thyroid disease, ‘Hypothyroidism: The Unsuspected Illness’ (later reviewed by Dr. Stephen Langer), and then the book ‘Hypothyroidism Type 2: The Epidemic’ by Dr. Mark Starr.  These will bring the rationale for diagnosing borderline or subclinical hypothyroidism into clear focus.

We should err on the side of more thyroid support for patients since there are so many contributors to low thyroid function, instead of putting doctors (and their patients) in harm’s way for practicing real medicine.

Garry F. Gordon MD,DO,MD(H)
President, Gordon Research Institute
www.gordonresearch.com

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Fertil Steril. 2010 Dec 28. [Epub ahead of print]

Effect of levothyroxine treatment on in vitro fertilization and pregnancy outcome in infertile women with subclinical hypothyroidism undergoing in vitro fertilization/intracytoplasmic sperm injection.

Kim CH, Ahn JW, Kang SP, Kim SH, Chae HD, Kang BM.
Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, South Korea.

Abstract

OBJECTIVE: To investigate whether levothyroxine (LT4) treatment has beneficial effects on IVF results and pregnancy outcome in infertile patients with subclinical hypothyroidism undergoing IVF/intracytoplasmic sperm injection (ICSI).

DESIGN: Prospective, randomized trial.

SETTING: University-affiliated infertility clinic.

PATIENT(S): A total of 64 infertile patients with subclinical hypothyroidism, defined as an elevated serum TSH level associated with a normal free T4 level and without frank symptoms of hypothyroidism.

INTERVENTION(S): Patients were randomized into an LT4 treatment group or control group. For the LT4 treatment group, 50 μg LT4 was administered from the first day of controlled ovarian stimulation for IVF/ICSI.

MAIN OUTCOME MEASURE(S): Results of IVF and pregnancy outcome.

RESULT(S): There were no differences in patient characteristics between the two groups. Total dose and days of recombinant human FSH used for controlled ovarian stimulation were also similar. The number of grade I or II embryos was significantly higher in the LT4 treatment group than in the control group. There was no significant difference in the clinical pregnancy rate per cycle between the two groups. However, the miscarriage rate was significantly lower in the LT4 treatment group than in the control group. Embryo implantation rate and live birth rate were significantly higher in the LT4 treatment group. In the control group, both thyroid peroxidase antibody and thyroglobulin antibody levels were significantly higher in the miscarried subgroup than in the delivered subgroup.

CONCLUSION(S): LT4 treatment can improve embryo quality and pregnancy outcome in subclinical hypothyroid women undergoing IVF/ICSI.

Copyright © 2011 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

PMID: 21193190 [PubMed – as supplied by publisher]

db=PubMed&dopt=Abstract&list_s=21193190


Beyond Thyroid Medication

November 6, 2008

Dead Tired

A number of my patients come into my office with a low functioning thyroid gland.  Typically they have symptoms including fatigue, weight gain that is difficult to overcome, thinning hair and mental “fog.” Nine times out of ten they have been prescribed Synthroid.  I will often re-test their blood levels of Thyroid Stimulating Hormone (TSH, T3 [active thyroid]) and TPO.  Additionally we have a medical test in our office called Thyroflex that tests the actual functioning of the thyroid gland.  I will then often switch my patients from Synthroid to Westhroid which is a natural alternative. One product I find beneficial for my patients who are not responding well to prescription Westhroid or who need additional support is Thyroid Support by Gaia Herbs.

I also find that patients with hypothyroid symptoms tend to have a vitamin B12 and iron deficiency, which is verified through blood tests we perform in our office.  Once that is treated, patients truly begin to feel better and their energy level, clarity of thought, and weight loss efforts dramatically improve.

And finally, for those patients that still do not feel fabulous after addressing thyroid function, I take a look at adrenal gland function and will test cortisol and DHEA levels in saliva to find out if the adrenal glands are playing a role, because adrenal gland function and thyroid function are interrelated.

In health,

Dr. G


%d bloggers like this: